Precision Medicine Study Highlights Role of Machine Learning

Snyder expects that machine learning will be able to complement the fields of precision medicine cancer genomics, transcriptomics and proteomics. "We launched this study because we wanted to begin marrying imaging to our'omics' studies to better understand cancer processes at a molecular level," he said. "This brings cancer pathology into the 21st century and has the potential to be an awesome thing for patients and their clinicians.